KEYTRUDA 25 mg/mL concentrate for solution for infusion
108439
Phase 3 small_molecule active
Quick answer
KEYTRUDA 25 mg/mL concentrate for solution for infusion for Advanced NSCLC is a Phase 3 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Advanced NSCLC
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active